Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Tur, MK; Sasse, S; Stocker, M; Djabelkhir, K; Huhn, M; Matthey, B; Gottstein, C; Pfitzner, T; Engert, A; Barth, S
   An anti-GD2 single chain Fv selected by phage display and fused to Pseudomonas exotoxin A develops specific cytotoxic activity against neuroblastoma derived cell lines
   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
   
   M.K. Tur et al., "An anti-GD2 single chain Fv selected by phage display and fused to Pseudomonas exotoxin A develops specific cytotoxic activity against neuroblastoma derived cell lines", INT J MOL M, 8(5), 2001, pp. 579-584
2. Mehes, G; Luegmayr, A; Ambros, IM; Ladenstein, R; Ambros, PF
   Combined automatic immunological and molecular cytogenetic analysis allowsexact identification and quantification of tumor cells in the bone marrow
   CLINICAL CANCER RESEARCH
   
   G. Mehes et al., "Combined automatic immunological and molecular cytogenetic analysis allowsexact identification and quantification of tumor cells in the bone marrow", CLIN CANC R, 7(7), 2001, pp. 1969-1975
3. Reuland, P; Geiger, L; Thelen, MH; Handgretinger, R; Haase, B; Muller-Schauenburg, W; Niethammer, D; Bares, R
   Follow-up in neuroblastoma: Comparison of metaiodobenzylguanidine and a chimeric anti-GD2 antibody for detection of tumor relapse and therapy response
   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
   
   P. Reuland et al., "Follow-up in neuroblastoma: Comparison of metaiodobenzylguanidine and a chimeric anti-GD2 antibody for detection of tumor relapse and therapy response", J PED H ONC, 23(7), 2001, pp. 437-442
4. Luo, HM; Ding, SY; Hsu, YY; Lin, BN; Ku, HC
   Weak ferromagnetism in distorted T '-phase cuprates
   PHYSICA C
   
   H.M. Luo et al., "Weak ferromagnetism in distorted T '-phase cuprates", PHYSICA C, 351(2), 2001, pp. 91-96
5. Mielcarek, S; Mroz, B; Tylczynski, Z; Piskunowicz, P; Trybula, Z; Bromberek, M
   Low-temperature thermal conductivity of ferroelastic Gd-2(MoO4)(3)
   PHYSICA B
   
   S. Mielcarek et al., "Low-temperature thermal conductivity of ferroelastic Gd-2(MoO4)(3)", PHYSICA B, 299(1-2), 2001, pp. 83-87
6. Kushner, BH; Kramer, K; Cheung, NKV
   Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma
   JOURNAL OF CLINICAL ONCOLOGY
   
   B.H. Kushner et al., "Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma", J CL ONCOL, 19(22), 2001, pp. 4189-4194
7. Stern, CA; Tiemeyer, M
   A ganglioside-specific sialyltransferase localizes to axons and non-Golgi structures in neurons
   JOURNAL OF NEUROSCIENCE
   
   C.A. Stern e M. Tiemeyer, "A ganglioside-specific sialyltransferase localizes to axons and non-Golgi structures in neurons", J NEUROSC, 21(5), 2001, pp. 1434-1443
8. Wachsman, M; Kulka, M; Smith, CC; Aurelian, L
   A growth and latency compromised herpes simplex virus type 2 mutant (ICP10Delta PK) has prophylactic and therapeutic protective activity in guinea pigs
   VACCINE
   
   M. Wachsman et al., "A growth and latency compromised herpes simplex virus type 2 mutant (ICP10Delta PK) has prophylactic and therapeutic protective activity in guinea pigs", VACCINE, 19(15-16), 2001, pp. 1879-1890
9. Wroblewski, JM; Bixby, DL; Borowski, C; Yannelli, JR
   Characterization of human non-small cell lung cancer (NSCLC) cell lines for expression of MHC, co-stimulatory molecules and tumor-associated antigens
   LUNG CANCER
   
   J.M. Wroblewski et al., "Characterization of human non-small cell lung cancer (NSCLC) cell lines for expression of MHC, co-stimulatory molecules and tumor-associated antigens", LUNG CANC, 33(2-3), 2001, pp. 181-194
10. Mehes, G; Luegmayr, A; Hattinger, CM; Lorch, T; Ambros, IM; Gadner, H; Ambros, PF
    Automatic detection and genetic profiling of disseminated neuroblastoma cells
    MEDICAL AND PEDIATRIC ONCOLOGY
    
    G. Mehes et al., "Automatic detection and genetic profiling of disseminated neuroblastoma cells", MED PED ONC, 36(1), 2001, pp. 205-209
11. Rossig, C; Bollard, CM; Nuchtern, JG; Merchant, DA; Brenner, MK
    Targeting of G(D2)-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes
    INTERNATIONAL JOURNAL OF CANCER
    
    C. Rossig et al., "Targeting of G(D2)-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes", INT J CANC, 94(2), 2001, pp. 228-236
12. Engler, S; Thiel, C; Forster, K; David, K; Bredehorst, R; Juhl, H
    A novel metastatic animal model reflecting the clinical appearance of human neuroblastoma: Growth arrest of orthotopic tumors by natural, cytotoxic human immunoglobulin M antibodies
    CANCER RESEARCH
    
    S. Engler et al., "A novel metastatic animal model reflecting the clinical appearance of human neuroblastoma: Growth arrest of orthotopic tumors by natural, cytotoxic human immunoglobulin M antibodies", CANCER RES, 61(7), 2001, pp. 2968-2973
13. Yoshida, S; Fukumoto, S; Kawaguchi, H; Sato, S; Ueda, R; Furukawa, K
    Ganglioside G(D2) in small cell lung cancer cell lines: Enhancement of cell proliferation and mediation of apoptosis
    CANCER RESEARCH
    
    S. Yoshida et al., "Ganglioside G(D2) in small cell lung cancer cell lines: Enhancement of cell proliferation and mediation of apoptosis", CANCER RES, 61(10), 2001, pp. 4244-4252
14. Shurin, GV; Shurin, MR; Bykovskaia, S; Shogan, J; Lotze, MT; Barksdale, EM
    Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function
    CANCER RESEARCH
    
    G.V. Shurin et al., "Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function", CANCER RES, 61(1), 2001, pp. 363-369
15. Kaucic, K; Etue, N; LaFleur, B; Woods, W; Ladisch, S
    Neuroblastomas of infancy exhibit a characteristic ganglioside pattern
    CANCER
    
    K. Kaucic et al., "Neuroblastomas of infancy exhibit a characteristic ganglioside pattern", CANCER, 91(4), 2001, pp. 785-793
16. Hoon, DSB; Kuo, CT; Wen, SH; Wang, H; Metelitsa, L; Reynolds, CP; Seeger, RC
    Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow
    AMERICAN JOURNAL OF PATHOLOGY
    
    D.S.B. Hoon et al., "Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow", AM J PATH, 159(2), 2001, pp. 493-500
17. Sorkin, LS
    Antibody activation and immune reactions: Potential linkage to pain and neuropathy
    PAIN MEDICINE
    
    L.S. Sorkin, "Antibody activation and immune reactions: Potential linkage to pain and neuropathy", PAIN MED, 1(4), 2000, pp. 296-302
18. Parkhomovskiy, N; Kammesheidt, A; Martin, PT
    N-acetyllactosamine and the CT carbohydrate antigen mediate agrin-dependent activation of MuSK and acetylcholine receptor clustering in skeletal muscle
    MOLECULAR AND CELLULAR NEUROSCIENCE
    
    N. Parkhomovskiy et al., "N-acetyllactosamine and the CT carbohydrate antigen mediate agrin-dependent activation of MuSK and acetylcholine receptor clustering in skeletal muscle", MOL CELL NE, 15(4), 2000, pp. 380-397
19. Vazquez, AM; Gabri, MR; Hernandez, AM; Alonso, DF; Beausoleil, I; Gomez, DE; Perez, R
    Antitumor properties of an anti-idiotypic monoclonal antibody in relation to N-glycolyl-containing gangliosides
    ONCOLOGY REPORTS
    
    A.M. Vazquez et al., "Antitumor properties of an anti-idiotypic monoclonal antibody in relation to N-glycolyl-containing gangliosides", ONCOL REP, 7(4), 2000, pp. 751-756
20. Zeytin, HE; Tripathi, PK; Bhattacharya-Chatterjee, M; Foon, KA; Chatterjee, SK
    Construction and characterization of DNA vaccines encoding the single-chain variable fragment of the anti-idiotype antibody 1A7 mimicking the tumor-associated antigen disialoganglioside GD2
    CANCER GENE THERAPY
    
    H.E. Zeytin et al., "Construction and characterization of DNA vaccines encoding the single-chain variable fragment of the anti-idiotype antibody 1A7 mimicking the tumor-associated antigen disialoganglioside GD2", CANC GENE T, 7(11), 2000, pp. 1426-1436
21. Ku, HC; Luo, HM; Lin, BN; Chi, YP; Hsu, YY; Sun, YP; Lee, TJ
    Effect of crystal symmetry on O '-phase weak ferromagnetism
    PHYSICA B
    
    H.C. Ku et al., "Effect of crystal symmetry on O '-phase weak ferromagnetism", PHYSICA B, 284, 2000, pp. 1373-1374
22. Lake, DF; Huynh, WC; Hersh, EM
    Natural and induced human antibody response to cancer
    CANCER INVESTIGATION
    
    D.F. Lake et al., "Natural and induced human antibody response to cancer", CANCER INV, 18(5), 2000, pp. 480-489
23. Kanazawa, J; Ohta, S; Shitara, K; Fujita, F; Fujita, M; Hanai, N; Akinaga, S; Okabe, M
    Therapeutic potential of chimeric anti-(ganglioside GD3) antibody KM871: antitumor activity in xenograft model of melanoma and effector function analysis
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    
    J. Kanazawa et al., "Therapeutic potential of chimeric anti-(ganglioside GD3) antibody KM871: antitumor activity in xenograft model of melanoma and effector function analysis", CANCER IMMU, 49(4-5), 2000, pp. 253-258
24. Bhattachary-Chatterjee, M; Baral, RN; Chatterjee, SK; Das, R; Zeytin, H; Chakraborty, M; Foon, KA
    Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versusmultiple-epitope antigen vaccine
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    
    M. Bhattachary-Chatterjee et al., "Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versusmultiple-epitope antigen vaccine", CANCER IMMU, 49(3), 2000, pp. 133-141
25. Chen, RL; Reynolds, CP; Seeger, RC
    Neutrophils are cytotoxic and growth-inhibiting for neuroblastoma cells with an anti-GD2 antibody but, without cytotoxicity, can be growth-stimulating
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    
    R.L. Chen et al., "Neutrophils are cytotoxic and growth-inhibiting for neuroblastoma cells with an anti-GD2 antibody but, without cytotoxicity, can be growth-stimulating", CANCER IMMU, 48(11), 2000, pp. 603-612
26. Brezicka, T; Bergman, B; Olling, S; Fredman, P
    Reactivity of monoclonal antibodies with ganglioside antigens in human small cell lung cancer tissues
    LUNG CANCER
    
    T. Brezicka et al., "Reactivity of monoclonal antibodies with ganglioside antigens in human small cell lung cancer tissues", LUNG CANC, 28(1), 2000, pp. 29-36
27. Bhattacharya-Chatterjee, M; Chatterjee, SK; Foon, KA
    Anti-idiotype vaccine against cancer
    IMMUNOLOGY LETTERS
    
    M. Bhattacharya-Chatterjee et al., "Anti-idiotype vaccine against cancer", IMMUNOL LET, 74(1), 2000, pp. 51-58
28. Lode, HN; Xiang, R; Perri, P; Pertl, U; Lode, A; Gillies, SD; Reisfeld, RA
    What to do with targeted IL-2
    DRUGS OF TODAY
    
    H.N. Lode et al., "What to do with targeted IL-2", DRUGS TODAY, 36(5), 2000, pp. 321-336
29. Lunn, MPT; Johnson, LA; Fromholt, SE; Itonori, S; Huang, J; Vyas, AA; Hildreth, JEK; Griffin, JW; Schnaar, RL; Sheikh, KA
    High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: Reexamination of GD1a immunolocalization
    JOURNAL OF NEUROCHEMISTRY
    
    M.P.T. Lunn et al., "High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: Reexamination of GD1a immunolocalization", J NEUROCHEM, 75(1), 2000, pp. 404-412
30. Aybar, MJ; Genta, SB; Riera, ANS; Sanchez, SS
    Participation of the GM1 ganglioside in the gastrulation of anuran amphibian Bufo arenarum
    JOURNAL OF EXPERIMENTAL ZOOLOGY
    
    M.J. Aybar et al., "Participation of the GM1 ganglioside in the gastrulation of anuran amphibian Bufo arenarum", J EXP ZOOL, 286(5), 2000, pp. 457-472
31. Kendra, K; Malkovska, V; Allen, M; Guzman, J; Albertini, M
    In vivo binding and antitumor activity of ch14.18
    JOURNAL OF IMMUNOTHERAPY
    
    K. Kendra et al., "In vivo binding and antitumor activity of ch14.18", J IMMUNOTH, 22(5), 1999, pp. 423-430
32. Bergman, I; Pohl, CR; Venkataramanan, R; Burckart, GJ; Stabin, M; Barmada, MA; Griffin, JA; Cheung, NKV
    Intrathecal administration of an anti-ganglioside antibody results in specific accumulation within meningeal neoplastic xenografts in nude rats
    JOURNAL OF IMMUNOTHERAPY
    
    I. Bergman et al., "Intrathecal administration of an anti-ganglioside antibody results in specific accumulation within meningeal neoplastic xenografts in nude rats", J IMMUNOTH, 22(2), 1999, pp. 114-123
33. Batova, A; Kamps, A; Gillies, SD; Reisfeld, RA; Yu, AL
    The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro
    CLINICAL CANCER RESEARCH
    
    A. Batova et al., "The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro", CLIN CANC R, 5(12), 1999, pp. 4259-4263
34. Bunn, PA
    Immune therapy for lung cancer - Are we getting closer?
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
    
    P.A. Bunn, "Immune therapy for lung cancer - Are we getting closer?", AM J RESP C, 21(1), 1999, pp. 10-12
35. Fonti, R; Cheung, NKV; Bridger, GJ; Guo, HF; Abrams, MJ; Larson, SM
    Tc-99m-Monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors
    NUCLEAR MEDICINE AND BIOLOGY
    
    R. Fonti et al., "Tc-99m-Monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors", NUCL MED BI, 26(6), 1999, pp. 681-686
36. Montaldo, PG; Pagnan, G; Raffaghello, L; Pastorino, F; Allen, TM; Kirchmeier, M; Ponzoni, M
    Anti GD2-immunoliposome-mediated targeting of [I-125] metaiodobenzylguanidine to neuroblastoma and melanoma cells in vitro
    JOURNAL OF LIPOSOME RESEARCH
    
    P.G. Montaldo et al., "Anti GD2-immunoliposome-mediated targeting of [I-125] metaiodobenzylguanidine to neuroblastoma and melanoma cells in vitro", J LIPOS RES, 9(3), 1999, pp. 367-385
37. Yates, AJ; Franklin, TK; McKinney, P; Collins, R; Comas, T; Boesel, CP; Pearl, DK
    Gangliosides and neutral glycolipids in ependymal, neuronal and primitive neuroectodermal tumors
    JOURNAL OF MOLECULAR NEUROSCIENCE
    
    A.J. Yates et al., "Gangliosides and neutral glycolipids in ependymal, neuronal and primitive neuroectodermal tumors", J MOL NEURO, 12(2), 1999, pp. 111-121
38. Qiu, JP; Luo, P; Wasmund, K; Steplewski, Z; Kieber-Emmons, T
    Towards the development of peptide mimotopes of carbohydrate antigens as cancer vaccines
    HYBRIDOMA
    
    J.P. Qiu et al., "Towards the development of peptide mimotopes of carbohydrate antigens as cancer vaccines", HYBRIDOMA, 18(1), 1999, pp. 103-112
39. Kim, SK; Ragupathi, G; Musselli, C; Choi, SJ; Park, YS; Livingston, PO
    Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugatecancer vaccines
    VACCINE
    
    S.K. Kim et al., "Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugatecancer vaccines", VACCINE, 18(7-8), 1999, pp. 597-603
40. Estevez, F; Carr, A; Solorzano, L; Valiente, O; Mesa, C; Barroso, O; Sierra, GV; Fernandez, LE
    Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP)
    VACCINE
    
    F. Estevez et al., "Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP)", VACCINE, 18(1-2), 1999, pp. 190-197
41. Hyuga, S; Yamagata, S; Takatsu, Y; Hyuga, M; Nakanishi, H; Furukawa, K; Yamagata, T
    Suppression by ganglioside GD1a of migration capability, adhesion to vitronectin and metastatic potential of highly metastatic FBJ-LL cells
    INTERNATIONAL JOURNAL OF CANCER
    
    S. Hyuga et al., "Suppression by ganglioside GD1a of migration capability, adhesion to vitronectin and metastatic potential of highly metastatic FBJ-LL cells", INT J CANC, 83(5), 1999, pp. 685-691
42. SEN G; CHAKRABORTY M; FOON KA; REISFELD RA; BHATTACHARYACHATTERJEE M
    INDUCTION OF IGG ANTIBODIES BY AN ANTIIDIOTYPE ANTIBODY MIMICKING DISIALOGANGLIOSIDE GD2
    Journal of immunotherapy
    
    G. Sen et al., "INDUCTION OF IGG ANTIBODIES BY AN ANTIIDIOTYPE ANTIBODY MIMICKING DISIALOGANGLIOSIDE GD2", Journal of immunotherapy, 21(1), 1998, pp. 75-83
43. FUKUDA M; HORIBE K; FURUKAWA K
    ENHANCEMENT OF IN-VITRO AND IN-VIVO ANTITUMOR-ACTIVITY OF ANTI-GD2 MONOCLONAL-ANTIBODY-220-51 AGAINST HUMAN NEUROBLASTOMA BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND GRANULOCYTE-COLONY-STIMULATING FACTOR
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    
    M. Fukuda et al., "ENHANCEMENT OF IN-VITRO AND IN-VIVO ANTITUMOR-ACTIVITY OF ANTI-GD2 MONOCLONAL-ANTIBODY-220-51 AGAINST HUMAN NEUROBLASTOMA BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND GRANULOCYTE-COLONY-STIMULATING FACTOR", INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2(4), 1998, pp. 471-475
44. KUO CT; BOSTICK PJ; IRIE RF; MORTON DL; CONRAD AJ; HOON DSB
    ASSESSMENT OF MESSENGER-RNA OF BETA-1-]4-N-ACETYLGALACTOSAMINYLTRANSFERASE AS A MOLECULAR MARKER FOR METASTATIC MELANOMAL
    Clinical cancer research
    
    C.T. Kuo et al., "ASSESSMENT OF MESSENGER-RNA OF BETA-1-]4-N-ACETYLGALACTOSAMINYLTRANSFERASE AS A MOLECULAR MARKER FOR METASTATIC MELANOMAL", Clinical cancer research, 4(2), 1998, pp. 411-418
45. KUO CT; BOSTICK PJ; IRIE RF; MORTON DL; CONRAD AJ; HOON DSB
    ASSESSMENT OF MESSENGER-RNA OF BETA-1-]4-N-ACETYLGALACTOSAMINYLTRANSFERASE AS A MOLECULAR MARKER FOR METASTATIC MELANOMAL
    Clinical cancer research
    
    C.T. Kuo et al., "ASSESSMENT OF MESSENGER-RNA OF BETA-1-]4-N-ACETYLGALACTOSAMINYLTRANSFERASE AS A MOLECULAR MARKER FOR METASTATIC MELANOMAL", Clinical cancer research, 4(2), 1998, pp. 411-418
46. CHEUNG NKV; KUSHNER BH; CHEUNG IY; KRAMER K; CANETE A; GERALD W; BONILLA MA; FINN R; YEH SJ; LARSON SM
    ANTI-GD(2) ANTIBODY TREATMENT OF MINIMAL RESIDUAL STAGE-4 NEUROBLASTOMA DIAGNOSED AT MORE THAN 1 YEAR OF AGE
    Journal of clinical oncology
    
    N.K.V. Cheung et al., "ANTI-GD(2) ANTIBODY TREATMENT OF MINIMAL RESIDUAL STAGE-4 NEUROBLASTOMA DIAGNOSED AT MORE THAN 1 YEAR OF AGE", Journal of clinical oncology, 16(9), 1998, pp. 3053-3060
47. YU AL; UTTENREUTHERFISCHER MM; HUANG CS; TSUI CC; GILLIES SD; REISFELD RA; KUNG FH
    PHASE-I TRIAL OF A HUMAN-MOUSE CHIMERIC ANTI-DISIALOGANGLIOSIDE MONOCLONAL-ANTIBODY CH14.18 IN PATIENTS WITH REFRACTORY NEUROBLASTOMA AND OSTEOSARCOMA
    Journal of clinical oncology
    
    A.L. Yu et al., "PHASE-I TRIAL OF A HUMAN-MOUSE CHIMERIC ANTI-DISIALOGANGLIOSIDE MONOCLONAL-ANTIBODY CH14.18 IN PATIENTS WITH REFRACTORY NEUROBLASTOMA AND OSTEOSARCOMA", Journal of clinical oncology, 16(6), 1998, pp. 2169-2180
48. SCHULTES BC; BAUM RP; NIESEN A; NOUJAIM AA; MADIYALAKAN R
    ANTIIDIOTYPE INDUCTION THERAPY - ANTI-CA125 ANTIBODIES (AB(3)) MEDIATED TUMOR KILLING IN PATIENTS TREATED WITH OVAREX MAB B43.13 (AB(1))
    Cancer immunology and immunotherapy
    
    B.C. Schultes et al., "ANTIIDIOTYPE INDUCTION THERAPY - ANTI-CA125 ANTIBODIES (AB(3)) MEDIATED TUMOR KILLING IN PATIENTS TREATED WITH OVAREX MAB B43.13 (AB(1))", Cancer immunology and immunotherapy, 46(4), 1998, pp. 201-212
49. SINGH M; CARLSON JR; BRIONES M; UGOZZOLI M; KAZZAZ J; BARACKMAN J; OTT G; OHAGAN D
    A COMPARISON OF BIODEGRADABLE MICROPARTICLES AND MF59 AS SYSTEMIC ADJUVANTS FOR RECOMBINANT GD FROM HSV-2
    Vaccine
    
    M. Singh et al., "A COMPARISON OF BIODEGRADABLE MICROPARTICLES AND MF59 AS SYSTEMIC ADJUVANTS FOR RECOMBINANT GD FROM HSV-2", Vaccine, 16(19), 1998, pp. 1822-1827
50. LODE HN; XIANG R; BECKER JC; GILLIES SD; REISFELD RA
    IMMUNOCYTOKINES - A PROMISING APPROACH TO CANCER-IMMUNOTHERAPY
    Pharmacology & therapeutics (Oxford)
    
    H.N. Lode et al., "IMMUNOCYTOKINES - A PROMISING APPROACH TO CANCER-IMMUNOTHERAPY", Pharmacology & therapeutics (Oxford), 80(3), 1998, pp. 277-292
51. OLSHEFSKI R; LADISCH S
    SYNTHESIS, SHEDDING, AND INTERCELLULAR TRANSFER OF HUMAN MEDULLOBLASTOMA GANGLIOSIDES - ABROGATION BY A NEW INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE
    Journal of neurochemistry
    
    R. Olshefski e S. Ladisch, "SYNTHESIS, SHEDDING, AND INTERCELLULAR TRANSFER OF HUMAN MEDULLOBLASTOMA GANGLIOSIDES - ABROGATION BY A NEW INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE", Journal of neurochemistry, 70(2), 1998, pp. 467-472
52. BRAMS P; NGUYEN ML; CHAMAT S; ROYSTON I; MORROW PR
    ANTIGEN-SPECIFIC IGG RESPONSES FROM NAIVE HUMAN SPLENOCYTES - IN-VITRO PRIMING FOLLOWED BY ANTIGEN BOOST IN THE SCID MOUSE
    The Journal of immunology
    
    P. Brams et al., "ANTIGEN-SPECIFIC IGG RESPONSES FROM NAIVE HUMAN SPLENOCYTES - IN-VITRO PRIMING FOLLOWED BY ANTIGEN BOOST IN THE SCID MOUSE", The Journal of immunology, 160(5), 1998, pp. 2051-2058
53. SIETSMA H; NIJHOF W; DONTJE B; VELLENGA E; KAMPS WA; KOK JW
    INHIBITION OF HEMATOPOIESIS IN-VITRO BY NEUROBLASTOMA-DERIVED GANGLIOSIDES
    Cancer research
    
    H. Sietsma et al., "INHIBITION OF HEMATOPOIESIS IN-VITRO BY NEUROBLASTOMA-DERIVED GANGLIOSIDES", Cancer research, 58(21), 1998, pp. 4840-4844
54. ZHANG ZQ; IRIE RF; CHI DDJ; HOON DSB
    CELLULAR IMMUNO-PCR - DEFECTION OF A CARBOHYDRATE TUMOR-MARKER
    The American journal of pathology
    
    Z.Q. Zhang et al., "CELLULAR IMMUNO-PCR - DEFECTION OF A CARBOHYDRATE TUMOR-MARKER", The American journal of pathology, 152(6), 1998, pp. 1427-1432
55. ALBERTINI MR; HANK JA; SCHILLER JH; KHORSAND M; BORCHERT AA; GAN J; BECHHOFER R; STORER B; REISFELD RA; SONDEL PM
    PHASE IB TRIAL OF CHIMERIC ANTIDISIALOGANGLIOSIDE ANTIBODY PLUS INTERLEUKIN-2 FOR MELANOMA PATIENTS
    Clinical cancer research
    
    M.R. Albertini et al., "PHASE IB TRIAL OF CHIMERIC ANTIDISIALOGANGLIOSIDE ANTIBODY PLUS INTERLEUKIN-2 FOR MELANOMA PATIENTS", Clinical cancer research, 3(8), 1997, pp. 1277-1288
56. FUKUMOTO S; YAMAMOTO A; HASEGAWA T; ABE K; TAKAMIYA K; OKADA M; MIN ZJ; FURUKAWA K; MIYAZAKI H; TSUJI Y; GOTO G; SUZUKI M; SHIKU H; FURUKAWA K
    GENETIC REMODELING OF GANGLIOSIDES RESULTED IN THE ENHANCED REACTIONSTO THE FOREIGN SUBSTANCES IN SKIN
    Glycobiology
    
    S. Fukumoto et al., "GENETIC REMODELING OF GANGLIOSIDES RESULTED IN THE ENHANCED REACTIONSTO THE FOREIGN SUBSTANCES IN SKIN", Glycobiology, 7(8), 1997, pp. 1111-1120
57. HEINEMANN S; SHARP TG; SEIFERT F; RUBIE DC
    THE CUBIC-TETRAGONAL PHASE-TRANSITION IN THE SYSTEM MAJORITE (MG4SI4O12) PYROPE (MG3AL2SI3O12), AND GARNET SYMMETRY IN THE EARTHS TRANSITION ZONE
    Physics and chemistry of minerals
    
    S. Heinemann et al., "THE CUBIC-TETRAGONAL PHASE-TRANSITION IN THE SYSTEM MAJORITE (MG4SI4O12) PYROPE (MG3AL2SI3O12), AND GARNET SYMMETRY IN THE EARTHS TRANSITION ZONE", Physics and chemistry of minerals, 24(3), 1997, pp. 206-221
58. SLART R; YU AL; YAKSH TL; SORKIN LS
    AN ANIMAL-MODEL OF PAIN PRODUCED BY SYSTEMIC ADMINISTRATION OF AN IMMUNOTHERAPEUTIC ANTIGANGLIOSIDE ANTIBODY
    Pain
    
    R. Slart et al., "AN ANIMAL-MODEL OF PAIN PRODUCED BY SYSTEMIC ADMINISTRATION OF AN IMMUNOTHERAPEUTIC ANTIGANGLIOSIDE ANTIBODY", Pain, 69(1-2), 1997, pp. 119-125
59. XIAO WH; YU AL; SORKIN LS
    ELECTROPHYSIOLOGICAL CHARACTERISTICS OF PRIMARY AFFERENT-FIBERS AFTERSYSTEMIC ADMINISTRATION OF ANTI-GD2 GANGLIOSIDE ANTIBODY
    Pain
    
    W.H. Xiao et al., "ELECTROPHYSIOLOGICAL CHARACTERISTICS OF PRIMARY AFFERENT-FIBERS AFTERSYSTEMIC ADMINISTRATION OF ANTI-GD2 GANGLIOSIDE ANTIBODY", Pain, 69(1-2), 1997, pp. 145-151
60. LADISCH S; CHANG FM; LI RX; COGEN P; JOHNSON D
    DETECTION OF MEDULLOBLASTOMA AND ASTROCYTOMA-ASSOCIATED GANGLIOSIDE C-D3 IN CEREBROSPINAL-FLUID
    Cancer letters
    
    S. Ladisch et al., "DETECTION OF MEDULLOBLASTOMA AND ASTROCYTOMA-ASSOCIATED GANGLIOSIDE C-D3 IN CEREBROSPINAL-FLUID", Cancer letters, 120(1), 1997, pp. 71-78
61. MOUTEL S; BIRKLE S; LAURENCE V; MICHON J; FRIDMAN WH; AUBRY J; TEILLAUD JL
    GENERATION AND CHARACTERIZATION OF A MOUSE SINGLE-CHAIN ANTIBODY FRAGMENT SPECIFIC FOR DISIALOGANGLIOSIDE (G(D2))
    Hybridoma
    
    S. Moutel et al., "GENERATION AND CHARACTERIZATION OF A MOUSE SINGLE-CHAIN ANTIBODY FRAGMENT SPECIFIC FOR DISIALOGANGLIOSIDE (G(D2))", Hybridoma, 16(4), 1997, pp. 335-346
62. HEISS P; BERMATZ S; WEHNES H; HEINZMANN U; SENEKOWITSCHSCHMIDTKE R
    DISTRIBUTION OF DISIALOGANGLIOSIDE G(D2)-ANTIGEN AND BINDING OF ANTI-G(D2) ANTIBODIES ON SPHEROIDS OF NEUROBLASTOMA CELL-LINE
    Anticancer research
    
    P. Heiss et al., "DISTRIBUTION OF DISIALOGANGLIOSIDE G(D2)-ANTIGEN AND BINDING OF ANTI-G(D2) ANTIBODIES ON SPHEROIDS OF NEUROBLASTOMA CELL-LINE", Anticancer research, 17(4B), 1997, pp. 3145-3147
63. JUHL H; PETRELLA EC; CHEUNG NKV; BREDEHORST R; VOGEL CW
    ADDITIVE CYTOTOXICITY OF DIFFERENT MONOCLONAL-ANTIBODY COBRA VENOM FACTOR CONJUGATES FOR HUMAN NEUROBLASTOMA-CELLS
    Immunobiology
    
    H. Juhl et al., "ADDITIVE CYTOTOXICITY OF DIFFERENT MONOCLONAL-ANTIBODY COBRA VENOM FACTOR CONJUGATES FOR HUMAN NEUROBLASTOMA-CELLS", Immunobiology, 197(5), 1997, pp. 444-459
64. RAVEENDRAN P; SUKUMAR N; SRINIVASAN TKK
    TEMPERATURE-DEPENDENCE OF PHONON-ASSISTED EXCITATION PROBABILITY IN GDTB(MOO4)(3) - EVIDENCE FOR A CHANGE IN ELECTRON-LATTICE COUPLING NEARA STRUCTURAL PHASE-TRANSITION
    Physical review. B, Condensed matter
    
    P. Raveendran et al., "TEMPERATURE-DEPENDENCE OF PHONON-ASSISTED EXCITATION PROBABILITY IN GDTB(MOO4)(3) - EVIDENCE FOR A CHANGE IN ELECTRON-LATTICE COUPLING NEARA STRUCTURAL PHASE-TRANSITION", Physical review. B, Condensed matter, 55(8), 1997, pp. 4978-4982
65. YUKI N; YAMADA M; TAGAAWA Y; TAKAHASHI H
    PATHOGENESIS OF THE NEUROTOXICITY CAUSED BY ANTI-GD2 ANTIBODY THERAPY
    Journal of the neurological sciences
    
    N. Yuki et al., "PATHOGENESIS OF THE NEUROTOXICITY CAUSED BY ANTI-GD2 ANTIBODY THERAPY", Journal of the neurological sciences, 149(2), 1997, pp. 127-130
66. RIGGOTT MJ; MATTHEW WD
    NEURITE OUTGROWTH IS ENHANCED BY ANTIIDIOTYPIC MONOCLONAL-ANTIBODIES TO THE GANGLIOSIDE GM1
    Experimental neurology
    
    M.J. Riggott e W.D. Matthew, "NEURITE OUTGROWTH IS ENHANCED BY ANTIIDIOTYPIC MONOCLONAL-ANTIBODIES TO THE GANGLIOSIDE GM1", Experimental neurology, 145(1), 1997, pp. 278-287
67. CHANG FM; LI RX; LADISCH S
    SHEDDING OF GANGLIOSIDES BY HUMAN MEDULLOBLASTOMA CELLS
    Experimental cell research
    
    F.M. Chang et al., "SHEDDING OF GANGLIOSIDES BY HUMAN MEDULLOBLASTOMA CELLS", Experimental cell research, 234(2), 1997, pp. 341-346
68. FROST JD; HANK JA; REAMAN GH; FRIERDICH S; SEEGER RC; GAN J; ANDERSON PM; ETTINGER LJ; CAIRO MS; BLAZAR BR; KRAILO MD; MATTHAY KK; REISFELD RA; SONDEL PM
    A PHASE I IB TRIAL OF MURINE MONOCLONAL ANTI-GD2 ANTIBODY 14.G2A PLUSINTERLEUKIN-2 IN CHILDREN WITH REFRACTORY NEUROBLASTOMA - A REPORT OFTHE CHILDRENS CANCER GROUP/
    Cancer
    
    J.D. Frost et al., "A PHASE I IB TRIAL OF MURINE MONOCLONAL ANTI-GD2 ANTIBODY 14.G2A PLUSINTERLEUKIN-2 IN CHILDREN WITH REFRACTORY NEUROBLASTOMA - A REPORT OFTHE CHILDRENS CANCER GROUP/", Cancer, 80(2), 1997, pp. 317-333
69. VRIESENDORP FJ; QUADRI SM; FLYNN RE; MALONE MR; CROMEENS DM; STEPHENS LC; VRIESENDORP HM
    PRECLINICAL ANALYSIS OF RADIOLABELED ANTI-GD2 IMMUNOGLOBULIN-G
    Cancer
    
    F.J. Vriesendorp et al., "PRECLINICAL ANALYSIS OF RADIOLABELED ANTI-GD2 IMMUNOGLOBULIN-G", Cancer, 80(12), 1997, pp. 2642-2649
70. DAVID K; OLLERT MW; JUHL H; VOLLMERT C; ERTTMANN R; VOGEL CW; BREDEHORST R
    GROWTH ARREST OF SOLID HUMAN NEUROBLASTOMA XENOGRAFTS IN NUDE RATS BYNATURAL IGM FROM HEALTHY HUMANS
    Nature medicine
    
    K. David et al., "GROWTH ARREST OF SOLID HUMAN NEUROBLASTOMA XENOGRAFTS IN NUDE RATS BYNATURAL IGM FROM HEALTHY HUMANS", Nature medicine, 2(6), 1996, pp. 686-689
71. ALBERTINI MR; GAN J; JAEGER P; HANK JA; STORER B; SCHELL K; RIVEST T; SURFUS J; REISFELD RA; SCHILLER JH; SONDEL PM
    SYSTEMIC INTERLEUKIN-2 MODULATES THE ANTIIDIOTYPIC RESPONSE TO CHIMERIC ANTI-GD2 ANTIBODY IN PATIENTS WITH MELANOMA
    Journal of immunotherapy with emphasis on tumor immunology
    
    M.R. Albertini et al., "SYSTEMIC INTERLEUKIN-2 MODULATES THE ANTIIDIOTYPIC RESPONSE TO CHIMERIC ANTI-GD2 ANTIBODY IN PATIENTS WITH MELANOMA", Journal of immunotherapy with emphasis on tumor immunology, 19(4), 1996, pp. 278-295
72. MURRAY JL; KLEINERMAN ES; JIA SF; ROSENBLUM MG; ETON O; BUZAID A; LEGHA S; ROSS MI; THOMPSON L; MUJOO K; RIEGER PT; SALEH M; KHAZAELI MB; VADHANRAJ S
    PHASE-IA IB TRIAL OF ANTI-GD2 CHIMERIC MONOCLONAL-ANTIBODY-14.18 (CH14.18) AND RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) IN METASTATIC MELANOMA/
    Journal of immunotherapy with emphasis on tumor immunology
    
    J.L. Murray et al., "PHASE-IA IB TRIAL OF ANTI-GD2 CHIMERIC MONOCLONAL-ANTIBODY-14.18 (CH14.18) AND RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) IN METASTATIC MELANOMA/", Journal of immunotherapy with emphasis on tumor immunology, 19(3), 1996, pp. 206-217
73. UGUR O; KOSTAKOGLU L; HUI ET; FISHER DR; GARMESTANI K; GANSOW OA; CHEUNG NKV; LARSON SM
    COMPARISON OF THE TARGETING CHARACTERISTICS OF VARIOUS RADIOIMMUNOCONJUGATES FOR RADIOIMMUNOTHERAPY OF NEUROBLASTOMA - DOSIMETRY CALCULATIONS INCORPORATING CROSS-ORGAN BETA DOSES
    Nuclear medicine and biology
    
    O. Ugur et al., "COMPARISON OF THE TARGETING CHARACTERISTICS OF VARIOUS RADIOIMMUNOCONJUGATES FOR RADIOIMMUNOTHERAPY OF NEUROBLASTOMA - DOSIMETRY CALCULATIONS INCORPORATING CROSS-ORGAN BETA DOSES", Nuclear medicine and biology, 23(1), 1996, pp. 1-8
74. RIGGOTT MJ; MATTHEW WD
    ANTIIDIOTYPIC MONOCLONAL-ANTIBODIES TO GM1 IDENTIFY GANGLIOSIDE BINDING-PROTEINS
    Glycobiology
    
    M.J. Riggott e W.D. Matthew, "ANTIIDIOTYPIC MONOCLONAL-ANTIBODIES TO GM1 IDENTIFY GANGLIOSIDE BINDING-PROTEINS", Glycobiology, 6(6), 1996, pp. 581-589
75. GRANT SC; KOSTAKOGLU L; KRIS MG; YEH SDJ; LARSON SM; FINN RD; OETTGEN HF; CHEUNG NKV
    TARGETING OF SMALL-CELL LUNG-CANCER USING THE ANTI-GD2 GANGLIOSIDE MONOCLONAL-ANTIBODY 3F8 - A PILOT TRIAL
    European journal of nuclear medicine
    
    S.C. Grant et al., "TARGETING OF SMALL-CELL LUNG-CANCER USING THE ANTI-GD2 GANGLIOSIDE MONOCLONAL-ANTIBODY 3F8 - A PILOT TRIAL", European journal of nuclear medicine, 23(2), 1996, pp. 145-149
76. SCHWARZ A; FUTERMAN AH
    THE LOCALIZATION OF GANGLIOSIDES IN NEURONS OF THE CENTRAL-NERVOUS-SYSTEM - THE USE OF ANTIGANGLIOSIDE ANTIBODIES
    Biochimica et biophysica acta, MR. Reviews on biomembranes
    
    A. Schwarz e A.H. Futerman, "THE LOCALIZATION OF GANGLIOSIDES IN NEURONS OF THE CENTRAL-NERVOUS-SYSTEM - THE USE OF ANTIGANGLIOSIDE ANTIBODIES", Biochimica et biophysica acta, MR. Reviews on biomembranes, 1286(3), 1996, pp. 247-267
77. LI RX; GAGE D; MCKALLIP R; LADISCH S
    STRUCTURAL CHARACTERIZATION AND IN-VIVO IMMUNOSUPPRESSIVE ACTIVITY OFNEUROBLASTOMA G(D2)
    Glycoconjugate journal
    
    R.X. Li et al., "STRUCTURAL CHARACTERIZATION AND IN-VIVO IMMUNOSUPPRESSIVE ACTIVITY OFNEUROBLASTOMA G(D2)", Glycoconjugate journal, 13(3), 1996, pp. 385-389
78. BISHOP JAN
    CURRENT IMMUNOTHERAPY FOR MELANOMA
    Cancer surveys
    
    J.A.N. Bishop, "CURRENT IMMUNOTHERAPY FOR MELANOMA", Cancer surveys, 26, 1996, pp. 321-333
79. RAVINDRANATH MH; BAUER PM; CORNILLEZTY C; GARCIA J; MORTON DL
    QUANTITATION OF THE DENSITY OF CELL-SURFACE CARBOHYDRATE ANTIGENS ON CANCER-CELLS WITH A SENSITIVE CELL-SUSPENSION ELISA
    Journal of immunological methods
    
    M.H. Ravindranath et al., "QUANTITATION OF THE DENSITY OF CELL-SURFACE CARBOHYDRATE ANTIGENS ON CANCER-CELLS WITH A SENSITIVE CELL-SUSPENSION ELISA", Journal of immunological methods, 197(1-2), 1996, pp. 51-67
80. FURUKAWA K; SOEJIMA H; NIIKAWA N; SHIKU H; FURUKAWA K
    GENOMIC ORGANIZATION AND CHROMOSOMAL ASSIGNMENT OF THE HUMAN BETA-1,4-N-ACETYLGALACTOSAMINYLTRANSFERASE GENE - IDENTIFICATION OF MULTIPLE TRANSCRIPTION UNITS
    The Journal of biological chemistry
    
    K. Furukawa et al., "GENOMIC ORGANIZATION AND CHROMOSOMAL ASSIGNMENT OF THE HUMAN BETA-1,4-N-ACETYLGALACTOSAMINYLTRANSFERASE GENE - IDENTIFICATION OF MULTIPLE TRANSCRIPTION UNITS", The Journal of biological chemistry, 271(34), 1996, pp. 20836-20844
81. TARDIF M; COULOMBE J; SOULIERES D; ROUSSEAU AP; PELLETIER G
    GANGLIOSIDES IN HUMAN UVEAL MELANOMA METASTATIC PROCESS
    International journal of cancer
    
    M. Tardif et al., "GANGLIOSIDES IN HUMAN UVEAL MELANOMA METASTATIC PROCESS", International journal of cancer, 68(1), 1996, pp. 97-101
82. LU P; SHAROM FJ
    IMMUNOSUPPRESSION BY YAC-1 LYMPHOMA - ROLE OF SHED GANGLIOSIDES
    Cellular immunology
    
    P. Lu e F.J. Sharom, "IMMUNOSUPPRESSION BY YAC-1 LYMPHOMA - ROLE OF SHED GANGLIOSIDES", Cellular immunology, 173(1), 1996, pp. 22-32
83. HELFAND SC; HANK JA; GAN J; SONDEL PM
    LYSIS OF HUMAN TUMOR-CELL LINES BY CANINE COMPLEMENT PLUS MONOCLONAL ANTIGANGLIOSIDE ANTIBODIES OR NATURAL CANINE XENOANTIBODIES
    Cellular immunology
    
    S.C. Helfand et al., "LYSIS OF HUMAN TUMOR-CELL LINES BY CANINE COMPLEMENT PLUS MONOCLONAL ANTIGANGLIOSIDE ANTIBODIES OR NATURAL CANINE XENOANTIBODIES", Cellular immunology, 167(1), 1996, pp. 99-107
84. MARQUINA G; WAKI H; FERNANDEZ LE; KON K; CARR A; VALIENTE O; PEREZ R; ANDO S
    GANGLIOSIDES EXPRESSED IN HUMAN BREAST-CANCER
    Cancer research
    
    G. Marquina et al., "GANGLIOSIDES EXPRESSED IN HUMAN BREAST-CANCER", Cancer research, 56(22), 1996, pp. 5165-5171
85. HANDGRETINGER R
    COMBINATION IMMUNOTHERAPY WITH MONOCLONAL-ANTIBODIES AND CYTOKINES FOR NEUROBLASTOMA
    International journal of pediatric hematology/oncology
    
    R. Handgretinger, "COMBINATION IMMUNOTHERAPY WITH MONOCLONAL-ANTIBODIES AND CYTOKINES FOR NEUROBLASTOMA", International journal of pediatric hematology/oncology, 2(6), 1995, pp. 495-501
86. MICHON J; PERDEREAU B; BRIXY F; MOUTEL S; FRIDMAN WH; TEILLAUD JL
    IN-VIVO TARGETING OF HUMAN NEUROBLASTOMA XENOGRAFT BY ANTI-G(D2)ANTI-FC-GAMMA-RI (CD64) BISPECIFIC ANTIBODY
    European journal of cancer
    
    J. Michon et al., "IN-VIVO TARGETING OF HUMAN NEUROBLASTOMA XENOGRAFT BY ANTI-G(D2)ANTI-FC-GAMMA-RI (CD64) BISPECIFIC ANTIBODY", European journal of cancer, 31A(4), 1995, pp. 631-636
87. HANDGRETINGER R; ANDERSON K; LANG P; DOPFER R; KLINGEBIEL T; SCHRAPPE M; REULAND P; GILLIES SD; REISFELD RA; NIETHAMMER D
    A PHASE-I STUDY OF HUMAN MOUSE CHIMERIC ANTIGANGLIOSIDE GD2 ANTIBODY CH14.18 IN PATIENTS WITH NEUROBLASTOMA
    European journal of cancer
    
    R. Handgretinger et al., "A PHASE-I STUDY OF HUMAN MOUSE CHIMERIC ANTIGANGLIOSIDE GD2 ANTIBODY CH14.18 IN PATIENTS WITH NEUROBLASTOMA", European journal of cancer, 31A(2), 1995, pp. 261-267
88. SATOH J; KIM SU
    GANGLIOSIDE MARKERS GD3, GD2, AND A2B5 IN FETAL HUMAN NEURONS AND GLIAL-CELLS IN CULTURE
    Developmental neuroscience
    
    J. Satoh e S.U. Kim, "GANGLIOSIDE MARKERS GD3, GD2, AND A2B5 IN FETAL HUMAN NEURONS AND GLIAL-CELLS IN CULTURE", Developmental neuroscience, 17(3), 1995, pp. 137-148
89. UTTENREUTHERFISCHER MM; HUANG CS; YU AL
    PHARMACOKINETICS OF HUMAN-MOUSE CHIMERIC ANTI-GD2 MAB CH14.18 IN A PHASE-I TRIAL IN NEUROBLASTOMA PATIENTS
    Cancer immunology and immunotherapy
    
    M.M. Uttenreutherfischer et al., "PHARMACOKINETICS OF HUMAN-MOUSE CHIMERIC ANTI-GD2 MAB CH14.18 IN A PHASE-I TRIAL IN NEUROBLASTOMA PATIENTS", Cancer immunology and immunotherapy, 41(6), 1995, pp. 331-338
90. HOLZER U; BETHGE W; KRULL F; IHLE J; HANDGRETINGER R; REISFELD RA; DOHLSTEN M; KALLAND T; NIETHAMMER D; DANNECKER GE
    UPERANTIGEN-STAPHYLOCOCCAL-ENTEROTOXIN-A-DEPENDENT AND ANTIBODY-TARGETED LYSIS OF GD(2)-POSITIVE NEUROBLASTOMA-CELLS
    Cancer immunology and immunotherapy
    
    U. Holzer et al., "UPERANTIGEN-STAPHYLOCOCCAL-ENTEROTOXIN-A-DEPENDENT AND ANTIBODY-TARGETED LYSIS OF GD(2)-POSITIVE NEUROBLASTOMA-CELLS", Cancer immunology and immunotherapy, 41(2), 1995, pp. 129-136
91. UTTENREUTHERFISCHER MM; HUANG CS; REISFELD RA; YU AL
    PHARMACOKINETICS OF ANTIGANGLIOSIDE GD2 MAB 14G2A IN A PHASE-I TRIAL IN PEDIATRIC CANCER-PATIENTS
    Cancer immunology and immunotherapy
    
    M.M. Uttenreutherfischer et al., "PHARMACOKINETICS OF ANTIGANGLIOSIDE GD2 MAB 14G2A IN A PHASE-I TRIAL IN PEDIATRIC CANCER-PATIENTS", Cancer immunology and immunotherapy, 41(1), 1995, pp. 29-36
92. BARBUTO JAM; GRIMES WJ; HERSH EM
    ANTIBODIES TO TUMOR-NECROSIS-FACTOR - A COMPONENT OF B-CELL IMMUNE-RESPONSES WITH A ROLE IN TUMOR HOST INTERACTION
    Cancer immunology and immunotherapy
    
    J.A.M. Barbuto et al., "ANTIBODIES TO TUMOR-NECROSIS-FACTOR - A COMPONENT OF B-CELL IMMUNE-RESPONSES WITH A ROLE IN TUMOR HOST INTERACTION", Cancer immunology and immunotherapy, 40(1), 1995, pp. 31-36
93. ARBIT E; CHEUNG NKV; YEH SDJ; DAGHIGHIAN F; ZHANG JJ; CORDONCARDO C; PENTLOW K; CANETE A; FINN R; LARSON SM
    QUANTITATIVE STUDIES OF MONOCLONAL-ANTIBODY TARGETING TO DISIALOGANGLIOSIDE G(D2) IN HUMAN BRAIN-TUMORS
    European journal of nuclear medicine
    
    E. Arbit et al., "QUANTITATIVE STUDIES OF MONOCLONAL-ANTIBODY TARGETING TO DISIALOGANGLIOSIDE G(D2) IN HUMAN BRAIN-TUMORS", European journal of nuclear medicine, 22(5), 1995, pp. 419-426
94. BOLETI E; GEORGE AJT; EPENETOS AA
    THERAPEUTIC MONOCLONALS
    Biochemical Society transactions
    
    E. Boleti et al., "THERAPEUTIC MONOCLONALS", Biochemical Society transactions, 23(4), 1995, pp. 1044-1047
95. MADIYALAKAN R; SYKES TR; DHARAMPAUL S; SYKES CJ; BAUM RP; HOR G; NOUJAIM AA
    ANTIIDIOTYPE INDUCTION THERAPY - EVIDENCE FOR THE INDUCTION OF IMMUNE-RESPONSE THROUGH THE IDIOTYPE NETWORK IN PATIENTS WITH OVARIAN-CANCERAFTER ADMINISTRATION OF ANTI-CA125 MURINE MONOCLONAL-ANTIBODY B43.13
    Hybridoma
    
    R. Madiyalakan et al., "ANTIIDIOTYPE INDUCTION THERAPY - EVIDENCE FOR THE INDUCTION OF IMMUNE-RESPONSE THROUGH THE IDIOTYPE NETWORK IN PATIENTS WITH OVARIAN-CANCERAFTER ADMINISTRATION OF ANTI-CA125 MURINE MONOCLONAL-ANTIBODY B43.13", Hybridoma, 14(2), 1995, pp. 199-203
96. KIKUMOTO Y; OKA T; CAO JN; SZE L; IRIE RF
    PEPTIDES WITH CARBOXYL-TERMINAL SEQUENCE OF ALANINE PROLINE - DETECTION BY A HUMAN MONOCLONAL-ANTIBODY
    Hybridoma
    
    Y. Kikumoto et al., "PEPTIDES WITH CARBOXYL-TERMINAL SEQUENCE OF ALANINE PROLINE - DETECTION BY A HUMAN MONOCLONAL-ANTIBODY", Hybridoma, 14(1), 1995, pp. 45-50
97. ZHAO XJ; CHEUNG NKV
    G(D2) OLIGOSACCHARIDE - TARGET FOR CYTOTOXIC T-LYMPHOCYTES
    The Journal of experimental medicine
    
    X.J. Zhao e N.K.V. Cheung, "G(D2) OLIGOSACCHARIDE - TARGET FOR CYTOTOXIC T-LYMPHOCYTES", The Journal of experimental medicine, 182(1), 1995, pp. 67-74
98. LU P; SHAROM FJ
    GANGLIOSIDES ARE POTENT IMMUNOSUPPRESSORS OF IL-2-MEDIATED T-CELL PROLIFERATION IN A LOW-PROTEIN ENVIRONMENT
    Immunology
    
    P. Lu e F.J. Sharom, "GANGLIOSIDES ARE POTENT IMMUNOSUPPRESSORS OF IL-2-MEDIATED T-CELL PROLIFERATION IN A LOW-PROTEIN ENVIRONMENT", Immunology, 86(3), 1995, pp. 356-363
99. MICHON J; MOUTEL S; BARBET J; ROMETLEMONNE JL; DEO YM; FRIDMAN WH; TEILLAUD JL
    IN-VITRO KILLING OF NEUROBLASTOMA-CELLS BY NEUTROPHILS DERIVED FROM GRANULOCYTE-COLONY-STIMULATING FACTOR-TREATED CANCER-PATIENTS USING AN ANTI-DISIALOGANGLIOSIDE ANTI-FC-GAMMA-RI BISPECIFIC ANTIBODY
    Blood
    
    J. Michon et al., "IN-VITRO KILLING OF NEUROBLASTOMA-CELLS BY NEUTROPHILS DERIVED FROM GRANULOCYTE-COLONY-STIMULATING FACTOR-TREATED CANCER-PATIENTS USING AN ANTI-DISIALOGANGLIOSIDE ANTI-FC-GAMMA-RI BISPECIFIC ANTIBODY", Blood, 86(3), 1995, pp. 1124-1130
100. DYATLOVITSKAYA EV
     SPHINGOLIPIDS AND MALIGNANT GROWTH
     Biochemistry
     
     E.V. Dyatlovitskaya, "SPHINGOLIPIDS AND MALIGNANT GROWTH", Biochemistry, 60(6), 1995, pp. 629-633